Publications by authors named "James D Neaton"

Claim this Profile
S
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.
Richard T Davey, Gary L Collins, Nadine Rouphael, Guillaume Poliquin, Rosemary McConnell, James D Neaton

Lancet Microbe· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Samuel M Brown, Christina E Barkauskas, Birgit Grund, Shweta Sharma, Andrew N Phillips, James D Neaton

Lancet Respir Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.
Hillary A Vanderven, Deborah N Wentworth, Win Min Han, Heidi Peck, Ian G Barr, James D Neaton

JCI Insight· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort.
Sandra E Safo, Lillian Haine, Jason Baker, Cavan Reilly, Daniel Duprez, James D Neaton

J Am Heart Assoc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study.
Mosoka P Fallah, Cavan Reilly, Collin Van Ryn, Moses Badio, Sia Wata Camanor, James D Neaton

Lancet Glob Health· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What motivates adults to accept influenza vaccine? An assessment of incentives, ease of access, messaging, and sources of information using a discrete choice experiment.
Kimberly E Bonner, Sandra Chyderiotis, Jonathan Sicsic, Judith E Mueller, Angela K Ulrich, James D Neaton

SSM Popul Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia.
Mosoka P Fallah, H Clifford Lane, Elizabeth S Higgs, Stephen B Kennedy, Moses B F Massaquoi, James D Neaton

Lancet Glob Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
Jens D Lundgren, Abdel G Babiker, Shweta Sharma, Birgit Grund, Andrew N Phillips, James D Neaton

NEJM Evid· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.

Ann Intern Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
David J Douin, Lianne Siegel, Greg Grandits, Andrew Phillips, Neil R Aggarwal, James D Neaton

Am J Respir Crit Care Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.

Ann Intern Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).
Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, Angela J Rogers, José Moltó, James D Neaton

Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
Laura I Levi, Shweta Sharma, Mark R Schleiss, Hansjakob Furrer, Daniel E Nixon, James D Neaton

AIDS· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19.
Katherine D Wick, Lianne Siegel, James D Neaton, Cathryn Oldmixon, Jens Lundgren

JCI Insight· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.
Kimberly E Bonner, Henry Ssekyanzi, Jonathan Sicsic, Judith E Mueller, Traci Toomey, James D Neaton

PLoS One· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
Daniel D Murray, Abdel G Babiker, Jason V Baker, Christina E Barkauskas, Samuel M Brown, James D Neaton

Clin Trials· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Emily A Blumberg, Gary Collins, Jo-Anne H Young, M Hong Nguyen, David Michonneau, James D Neaton

Transpl Infect Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.

Ann Intern Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolite profiles associated with disease progression in influenza infection.
Chris H Wendt, Sandra Castro-Pearson, Jennifer Proper, Sarah Pett, Timothy J Griffin, James D Neaton

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B Kennedy, James D Neaton

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
Christina Ekenberg, Joanne Reekie, Adrian G Zucco, Daniel D Murray, Shweta Sharma, James D Neaton

AIDS· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.

N Engl J Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibody for Patients with Covid-19. Reply.
Jens D Lundgren, H Clifford Lane, James D Neaton

N Engl J Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Ebola Virus-Associated Eye Disease.
Allen O Eghrari, Rachel J Bishop, Robin D Ross, Bionca Davis, Jemma Larbelee, James D Neaton

JAMA Netw Open· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B Kennedy, James D Neaton

Trials· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis